E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 11
7 / 11Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Case Report
Online Published: 03 Jan 2021
 


Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report

Cucunawangsih Cucunawangsih, Andree Kurniawan, Nata Pratama Hardjo Lugito.


Abstract
Micafungin is an echinocandin-class antifungal agent that is extremely used in the recent era due to minimal toxicity and broad-spectrum activity, unfortunately has limited ability against Cryptococcus neoformans. Since it’s inherently resistant, indeed disseminated invasive cryptococcosis is becoming an important issue in echinocandin recipient with impaired immunity. We present a patient with systemic lupus erythematosus and miliary tuberculosis, who developed a fungal infection with invasive cryptococcal fungemia during empirical micafungin therapy. To the best of our knowledge, breakthrough disseminated cryptococcosis has not been reported, as seen in our patient. This case highlighted that Cryptococcus neoformans infection should be kept in mind as a possible breakthrough infection while receiving echinocandin, especially in patients with cellular immunodeficiency.

Key words: invasive fungal infection, micafungin, Cryptococcus neoformans


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Cucunawangsih Cucunawangsih
Articles by Andree Kurniawan
Articles by Nata Pratama Hardjo Lugito
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Cucunawangsih C, Kurniawan A, Lugito NPH. Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report. Int J Med Rev Case Rep. 2021; 5(2): 25-30. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia

Web Style

Cucunawangsih C, Kurniawan A, Lugito NPH. Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report. https://www.mdpub.net/?mno=13481 [Access: October 13, 2024]. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia

AMA (American Medical Association) Style

Cucunawangsih C, Kurniawan A, Lugito NPH. Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report. Int J Med Rev Case Rep. 2021; 5(2): 25-30. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia


Vancouver/ICMJE Style

Cucunawangsih C, Kurniawan A, Lugito NPH. Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report. Int J Med Rev Case Rep. (2021), [cited October 13, 2024]; 5(2): 25-30. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia


Harvard Style

Cucunawangsih, C., Kurniawan, . A. & Lugito, . N. P. H. (2021) Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report. Int J Med Rev Case Rep, 5 (2), 25-30. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia


Turabian Style

Cucunawangsih, Cucunawangsih, Andree Kurniawan, and Nata Pratama Hardjo Lugito. 2021. Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report. International Journal of Medical Reviews and Case Reports, 5 (2), 25-30. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia


Chicago Style

Cucunawangsih, Cucunawangsih, Andree Kurniawan, and Nata Pratama Hardjo Lugito. "Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report." International Journal of Medical Reviews and Case Reports 5 (2021), 25-30. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia


MLA (The Modern Language Association) Style

Cucunawangsih, Cucunawangsih, Andree Kurniawan, and Nata Pratama Hardjo Lugito. "Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report." International Journal of Medical Reviews and Case Reports 5.2 (2021), 25-30. Print. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia


APA (American Psychological Association) Style

Cucunawangsih, C., Kurniawan, . A. & Lugito, . N. P. H. (2021) Breakthrough Invasive Disseminated Cryptococcal Fungemia in a Patient Receiving Micafungin Therapy: A Case Report. International Journal of Medical Reviews and Case Reports, 5 (2), 25-30. doi:10.5455/IJMRCR.Disseminated-Cryptococcal-Fungemia


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500